|
2023
|
Invention
|
Lactate enhancing compounds and uses thereof. The present invention relates to new agents useful ... |
|
2022
|
Invention
|
Meroterpenoid compounds for use in the prevention and treatment of a neurological disorder.
The ... |
|
|
Invention
|
Polyketide compound and derivatives thereof for use in the prevention and treatment of a neurolog... |
|
2021
|
Invention
|
Compositions and methods of treatment for neurological disorders comprising a dementia.
This inv... |
|
|
Invention
|
Compositions and methods of treatment for neurological disorders comprising motor neuron diseases... |
|
|
Invention
|
Compositions and methods of treatment for neurological disorders comprising depression.
This inv... |
|
2020
|
Invention
|
Isoquinoline derivatives for use in treating glut1 deficiency syndrome. The present invention rel... |
|
2019
|
Invention
|
Compositions and methods of treatment for neurological disorders comprising depression. This inve... |
|
|
Invention
|
Lactate enhancing compounds and uses thereof.
The present invention relates to new agents useful... |
|
|
Invention
|
Lactate enhancing compounds and uses thereof. Abstract of the invention: The present invention re... |
|
2018
|
Invention
|
Compositions and methods of treatment for neurological disorders comprising a dementia. This inve... |
|
|
Invention
|
Meroterpenoid compounds for use in the prevention and treatment of a neurological disorder. The p... |
|
2016
|
P/S
|
Clinical trials, scientific laboratory services, biological research, scientific research, resear... |
|
|
P/S
|
Biological preparations for medical use,
chemico-pharmaceutical preparations, chemical preparati... |
|
2013
|
Invention
|
4-oxo-2-pentenoic acid and brain health. The present invention relates generally to compositions ... |
